<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0177195.ref062">
 <label>62</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Hill</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Khoo</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Fortunak</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>Simmons</surname>
   <given-names>B</given-names>
  </name>, 
  <name>
   <surname>Ford</surname>
   <given-names>N</given-names>
  </name>. 
  <article-title>Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries</article-title>. 
  <source>Clinical infectious diseases: an official publication of the Infectious Diseases Society of America</source>. 
  <year>2014</year>;
  <volume>58</volume>(
  <issue>7</issue>):
  <fpage>928</fpage>â€“
  <lpage>36</lpage>. 
  <pub-id pub-id-type="doi">10.1093/cid/ciu012</pub-id>
  <pub-id pub-id-type="pmid">24399087</pub-id>
 </mixed-citation>
</ref>
